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Abstract Xenopus oocyte meiotic maturation combines features
of G0/G1 and G2/M transitions of the cell cycle. To study the in
ovo Rb kinase activity, we have microinjected human Rb into
oocytes. Microinjected human Rb localizes into the nucleus, is
hypophosphorylated in prophase oocytes, becomes hyperphos-
phorylated during meiotic maturation and is dephosphorylated as
the cell reenters interphase. Inactivation or overexpression of the
cyclin D-cdk4/6 complex in an oocyte extract does not affect the
Rb kinase activity. This kinase activity could be attributed to
both cdc2-cyclin B and MAP kinase, opening new perspectives of
investigation in somatic cells.
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1. Introduction
The Xenopus oocyte is arrested in meiotic prophase I. The
prophase release is dependent on extracellular signals: both
progesterone and insulin-like growth factor 1 (IGF-1) are able
to induce meiotic divisions. These signals induce various bio-
chemical pathways that ultimately activate the cdc2-cyclin B
kinase. The oocyte then arrests at metaphase II [1]. Therefore,
meiotic maturation clearly resembles a G2/M transition. Dur-
ing this process, kinases such as mitogen-activated protein
(MAP) kinase [2] or c-raf kinase [3,4] are also activated. In
somatic cells, the growth factor-induced transduction cascades
recruiting these kinases will ultimately be tied to elements of
the cell cycle. In the oocyte, kinases such as c-raf and MAP
kinase are activated at the same time as the cdc2-cyclin B
complex, just before breakdown of the nuclear envelope
(GVBD or germinal vesicle breakdown) [3^6]. Oocyte pro-
phase release therefore shares common features with a G0/
G1 transition, a resemblance emphasized by involvement of
G1 cyclins like cyclin A [7], cyclin E [8,9] and cyclin D2.
Xenopus cyclin D2 has been cloned recently and appears to
be the only D-type cyclin expressed at the mRNA level in the
oocytes [10]. Similarly to their roles in G0/G1/S transitions,
these cyclins could be involved in induction of meiosis reini-
tiation. The major target of G1 cdk-cyclins in somatic cells is
the retinoblastoma gene product, Rb, which has been demon-
strated to be present in Xenopus oocytes [11].
Rb has the ability to suppress cell proliferation and this
activity is controlled by its cell cycle-dependent phosphoryla-
tion. Rb phosphorylation begins in late G1 and continues
until M phase [12]. The hypophosphorylated forms of Rb
found in G1 are active during growth suppression by binding
and inhibiting the transcription factor E2F, while hyperphos-
phorylated forms found during other cell cycle phases are
inactive [13]. At least three di¡erent cdks are involved in the
phosphorylation of Rb during the G1 and S phase of the
somatic cell cycle [12]. Cyclin D-cdk4/6 complexes are most
prominently implicated in the phosphorylation of Rb. In-
volvement of cyclin E in the phosphorylation of Rb is also
strongly suggested. Rb might also be a physiological substrate
for cyclin A-dependent kinase. At G2 and M phases, cyclin B-
cdc2 might also contribute to the phosphorylation of Rb [12].
Since all cdks involved in Rb phosphorylation and some
kinases involved in mitogenic transduction pathways such as
MAP kinase are present and activated during meiotic matu-
ration, the oocyte model system could contribute to the mo-
lecular identi¢cation and characterization of the in vivo Rb
kinases. We therefore used the oocyte as a test tube to study
the in vivo activity levels of Rb kinase after microinjection of
its substrate, Rb, into the oocyte. Microinjected human Rb is
hyperphosphorylated during meiotic maturation at the time of
nuclear envelope breakdown in parallel with the appearance
of a measurable Rb kinase activity in oocyte extracts. Surpris-
ingly, cyclins E and D2 and cdk2 and cdk4 do not contribute
to the in ovo Rb kinase activity, which could rather be attrib-
uted to MAP kinase and the cdc2-cyclin B complex.
2. Materials and methods
2.1. Materials
Xenopus laevis adult females (CNRS, Rennes, France) were bred
and maintained under laboratory conditions. [Q-32P]ATP (s 3000
Ci/mmol) was obtained from NEN. Reagents were from Sigma, unless
otherwise speci¢ed.
2.2. Preparation and treatments of oocytes
Isolated oocytes were prepared as in [5]. Prophase oocytes were
induced to mature by addition of 1 WM progesterone. Activation of
metaphase II oocytes was induced by electric shock as in [14] and
oocytes were collected 30 min later. For microinjection, 50 nl of sam-
ple was microinjected into each oocyte. Enucleation of prophase oo-
cytes and nucleus preparation were performed as described [15].
2.3. Extract preparation
Batches of 100 oocytes were homogenized in 400 Wl EB [5] at 4‡C
and centrifuged at 15 000Ug at 4‡C for 30 min. The supernatant was
used for assaying kinase activities or for immunoblotting. In some
cases, this extract was then centrifuged at 100 000Ug for 1 h at
4‡C. GST-Rb was isolated from microinjected oocytes by incubating
the 15 000Ug extract for 60 min at 4‡C in the presence of glutathione-
Sepharose beads (Pharmacia). Beads were then washed and resus-
pended in Laemmli sample bu¡er [16] before immunoblotting. In
the case of alkaline phosphatase treatment, Rb isolated from oocytes
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and bound to glutathione-Sepharose beads was incubated for 20 min
at 30‡C in 50 Wl phosphatase bu¡er (Tris pH 8.5, 0.1% L-mercapto-
ethanol) containing 5 U alkaline phosphatase before adding Laemmli
sample bu¡er.
2.4. In vitro activation of cdc2 and MAP kinase
A 100 000Ug extract from 100 prophase oocytes was supplemented
with an ATP-regenerating system (1 mM ATP, 1 mM MgCl2, 10 mM
phosphocreatine, 50 Wg/ml creatine kinase) and then incubated at
23‡C for 3 h with either 1 Wg/ml GST-cdc25A or 500 nM okadaic
acid (ICN) or 500 nM okadaic acid and 10 Wg/ml p21CIP1 or control
EB bu¡er. Samples were collected either for Western blot analysis
with an anti-MAP kinase or for Rb kinase and histone H1 kinase
assays.
2.5. Kinase assays
For p13 binding of cdc2-cyclin B and histone H1 kinase assays,
extracts corresponding to 10 oocytes were diluted in 100 Wl EB and
then processed with p13-Sepharose beads according to [5]. Cdc2-cyclin
B kinase activity was also assayed in anti-cyclin B2 immunoprecipi-
tates. For cdc2-cyclin A and cdk2-cyclin A kinase assays, recombinant
GST-cdc2 (33 Wg/ml) or GST-cdk2 (33 Wg/ml) was incubated with
puri¢ed cyclin A (16 Wg/ml) and phosphorylated on threonine-161
and 160 respectively by addition of pure civ1 kinase (50 Wg/ml) (kindly
provided by Dr. C. Mann, CEA, France [17]) in the presence of
100 WM ATP. Complexes were then isolated on glutathione-Sepharose
beads (Pharmacia), washed in kinase bu¡er [5] and processed for
kinase assays. Active thiophosphorylated bacterially expressed MAP
kinase was puri¢ed as described in [18]. Kinase assays were performed
in 50 Wl kinase bu¡er containing 10 WM [Q-32P]ATP (2 WCi) and either
10 Wg histone H1 (Boehringer Mannheim) or 125 Wg myelin basic
protein (MBP) or 2 Wg soluble Rb for 30 min at 30‡C. The reactions
were stopped by adding Laemmli sample bu¡er and by boiling at
100‡C for 5 min before SDS-PAGE and autoradiography. The bands
of histone H1, MBP and Rb were excised from the gel and counted.
In some cases, Rb bound to glutathione-Sepharose beads (Pharmacia)
was used as a substrate. Extracts were incubated in the presence of Rb
bound to glutathione-Sepharose beads and 10 WM [Q-32P]ATP (2 WCi)
for 30 min at 30‡C. Beads were then extensively washed before adding
Laemmli sample bu¡er.
2.6. Immunoblotting
Proteins were electrophoresed and transferred to nitrocellulose ¢l-
ters as described [5]. The mouse monoclonal anti-human Rb antibody
(X2160) was provided by Dr. E. Harlow (Harvard Medical School,
USA) [19] and the rabbit polyclonal anti-GST antibody was provided
by Dr. K. Galaktionov (CSHL, USA) [10]. Anti-GST (1:250 dilution)
and anti-MAP kinase (1:3000 dilution, anti-ERK1, Santa Cruz) anti-
bodies were revealed with HRP-conjugated swine anti-rabbit antibody
(Dako). Anti-Rb antibody (1:1 dilution) was revealed with HRP-con-
jugated rabbit anti-mouse antibody (Dako). ECL Western blotting
detection system was from NEN.
2.7. Bacterial production of recombinant proteins
Glutathione S-transferase (GST) fusion Xenopus cyclin D2 protein
expression and puri¢cation have been described in [10]. An identical
procedure was used to express GST-human p16INK4 (pGEX-KG-p16
plasmid kindly provided by Dr. M. Serrano, CSHL, USA), GST-
human p21CIP1 (pGEX-KG/p21 plasmid kindly provided by Dr. H.
Zhang, CSHL, USA), GST-human large pocket Rb (pGEX-GST-Rb
plasmid kindly provided by Dr. B. Ducommun, CNRS, France) and
GST-human cdc25A (pGEX-KG-human cdc25A provided by Dr. K.
Galaktionov, CSHL, USA). GST-Xenopus cdk4, GST-Xenopus cdk2
and GST-Xenopus cdc2 (pGEX-Xenopus cdk4 plasmid, pGEX-KG-
Xenopus cdc2 and pGEX-KG-Xenopus cdk2 plasmids kindly provided
by Dr. T. Hunt, ICRF, UK) were puri¢ed according to [20]. Human
cyclin A (pT7f1 plasmid kindly provided by Dr. C. BreŁchot, IN-
SERM, France) was produced as described in [21].
3. Results
3.1. Microinjected Rb localizes into the nucleus
Although Xenopus Rb protein was shown to be expressed at
a low level in metaphase II oocytes by immunoblotting [11],
we were unable to detect the endogenous Xenopus Rb protein
by using the same monoclonal antibody, since the Rb concen-
tration is below the detectable level and since the monoclonal
anti-human Rb antibody has a low a⁄nity for the Xenopus
protein. To study the oocyte Rb kinase activity, we micro-
injected GST-Rb into prophase oocytes. To ascertain the rele-
vance of Rb microinjection, we ¢rst investigated the intracel-
lular localization of GST-Rb. In somatic cells, Rb localizes
almost exclusively into the nucleus, where it controls tran-
scription of various genes through binding to transcription
factors [12]. Prophase oocytes were microinjected with GST-
Rb and then enucleated. Nuclei, enucleated oocytes and entire
oocytes were subjected to immunoblotting with an anti-GST
antibody. In non-injected oocytes, the antibody recognizes a
thin 25 kDa band, corresponding to Xenopus GST (Fig. 1,
lane 1). In GST-Rb-injected whole oocytes, the antibody rec-
ognizes a 70 kDa band, the expected molecular weight of
GST-Rb, and a 25 kDa band corresponding to a mixture of
endogenous GST and bacterially expressed GST present in the
GST-Rb preparation (Fig. 1, lane 2). In GST-Rb-injected
enucleated oocytes, the amount of GST-Rb is diminished
whereas the quantity of GST is una¡ected (Fig. 1, lane 3).
As expected, nuclei isolated from GST-Rb-injected oocytes
exhibit a strong band of GST-Rb whereas GST appears ex-
cluded from the nucleus (Fig. 1, lane 4). Taking into account
the volume of the nucleus (8U106 Wm3) versus the volume of
the cytoplasm (900U106 Wm3 total oocyte volume including
vitellus, 450U106 Wm3 of active cytoplasm) and by scanning
the bands revealed by immunoblotting, the concentration of
GST-Rb was found to be 37 times higher in the nucleus than
in the cytoplasm.
3.2. In vivo phosphorylation of microinjected Rb during meiotic
maturation
To study the oocyte Rb kinase, GST-Rb was microinjected
into prophase oocytes. Oocytes were then exposed to proges-
terone in order to induce meiotic maturation. Metaphase II
oocytes were eventually activated by electric shock, a treat-
ment mimicking the early events induced by fertilization: the
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Fig. 1. Intracellular localization of microinjected GST-Rb into Xe-
nopus prophase oocytes. Prophase oocytes were microinjected with
bacterially expressed GST-Rb. Two hours after microinjection, they
were enucleated. Immunoblotting with an anti-GST antibody of
three non-injected prophase oocytes (lane 1), three GST-Rb-injected
prophase oocytes (lane 2), three GST-Rb-injected prophase oocytes
after enucleation (lane 3) and 11 nuclei from GST-Rb-injected pro-
phase oocytes (lane 4). Arrows point to the position of human
GST-Rb and GST. Positions of molecular weight markers are indi-
cated on the left (kDa).
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cell reenters interphase. Microinjected GST-Rb was isolated
from prophase, GVBD, metaphase II and activated oocytes
by a⁄nity binding on glutathione-Sepharose beads and de-
tected by immunoblotting with two antibodies: an anti-GST
antibody recognizing the GST tag of the protein, and a mono-
clonal anti-human Rb antibody. Both antibodies recognize a
70 kDa band in microinjected oocytes, corresponding to GST-
Rb (Fig. 2). GST-Rb is much less recognized by the mono-
clonal anti-Rb antibody in metaphase II oocytes than in pro-
phase and activated oocytes (Fig. 2A). In addition, the mobil-
ity of the poorly recognized metaphase form is retarded in
comparison with both other forms (Fig. 2A). In contrast, the
same amount of GST-Rb is recognized by the anti-GST anti-
body in prophase, GVBD, metaphase II and activated oocytes
(Fig. 2B), demonstrating that the microinjected protein is sta-
ble all over the meiotic cell cycle. The forms isolated from
oocytes at GVBD and metaphase II migrate more slowly
than both other forms (Fig. 2B). These observations suggest
that GST-Rb is modi¢ed transiently during meiotic matura-
tion starting GVBD. The modi¢cation observed in GVBD
and metaphase II oocytes decreases the a⁄nity of the mono-
clonal anti-Rb antibody towards Rb (Fig. 2A) and retards the
migration of the protein (Fig. 2A,B).
To investigate the possibility that this modi¢cation corre-
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Table 1
Speci¢c activity of various protein kinases towards histone H1, MBP and Rb in vitro
Cdk2-cyclin A Cdc2-cyclin A Cdc2-cyclin B MAP kinase
Histone H1 1.250 0.354 6.941 0.107
MBP ND ND 5.253 15.530
Rb 0.116 0 0.514 7.605
The cdc2-cyclin A and cdk2-cyclin A complexes were reconstituted and phosphorylated on threonine-161 and 160 in vitro by using bacterially
expressed recombinant proteins. The cdc2-cyclin B complex was immunoprecipitated from metaphase II oocytes with an anti-cyclin B2 antibody.
MAP kinase is an active thiophosphorylated bacterially expressed Xenopus form. Activities are expressed as pmol P incorporated/Wg of enzyme/min
at 30‡C. ND: not determined.
Fig. 2. Reversible phosphorylation of microinjected Rb during meiotic maturation. Prophase oocytes were microinjected with 0.1 mg/ml bacteri-
ally expressed GST-Rb and were incubated 2 h later in the presence of 1036 M progesterone. Prophase, GVBD, metaphase II and activated oo-
cytes were then collected and microinjected GST-Rb was isolated on glutathione-Sepharose beads. A: Immunoblotting with an anti-human Rb
antibody of GST-Rb from prophase oocytes (lane 1), from metaphase II oocytes (lane 2) and from activated oocytes (lane 3). B: Immunoblot-
ting with an anti-GST antibody of GST-Rb from prophase oocytes (lane 1), from GVBD oocytes (lane 2), from metaphase II oocytes (lane 3)
and from activated oocytes (lane 4). C, D: Immunoblotting with an anti-human Rb antibody (C) and with an anti-GST antibody (D) of GST-
Rb from prophase oocytes (lanes 1 and 2) and from GVBD oocytes (lanes 3 and 4). After extraction on glutathione-Sepharose beads, GST-Rb
was incubated in the absence (lanes 1 and 3) or in the presence (lanes 2 and 4) of 5 U alkaline phosphatase. Arrows point to the position of
human GST-Rb and GST. Positions of molecular weight markers are indicated on the left (kDa).
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sponds to a phosphorylation event, the same experiment was
repeated with prophase and GVBD microinjected oocytes by
introducing a phosphatase treatment after extraction of GST-
Rb and before immunoblotting. After phosphatase treatment,
the a⁄nity of the monoclonal anti-Rb antibody towards GST-
Rb extracted from GVBD oocytes strongly reincreases (Fig.
2C). Similarly, phosphatase treatment accelerates Rb mobility
of GVBD oocytes as revealed with the anti-GST antibody
(Fig. 2D). This result indicates that Rb is phosphorylated at
GVBD and in metaphase oocytes, and that the phosphoryl-
ated form exhibits a lower a⁄nity for the anti-Rb antibody
and a retarded mobility in the gel.
Interestingly, the prophase form of Rb was also a¡ected by
the phosphatase treatment, to a lesser extent than the GVBD
form: its a⁄nity for the monoclonal anti-Rb antibody and its
mobility are also increased (Fig. 2C,D). After phosphatase
treatment, both prophase and GVBD Rb forms behave iden-
tically in terms of a⁄nity for the monoclonal anti-Rb anti-
body and migration, although the non-treated forms are ob-
viously di¡erent. This result strongly suggests that Rb is
hypophosphorylated in prophase whereas Rb is hyperphos-
phorylated in GVBD oocytes.
3.3. A Rb kinase is transiently activated during meiotic
maturation
To assay the Rb kinase activity, 15 000Ug extracts were
prepared from prophase, metaphase II and activated oocytes
and incubated with GST-Rb bound on glutathione-Sepharose
beads in the presence of [Q-32P]ATP. Beads were then washed
out and loaded on SDS-PAGE. Phosphorylation of GST-Rb
by the various extracts was analyzed by autoradiography (Fig.
3A). GST-Rb is not phosphorylated by prophase oocyte ex-
FEBS 20058 3-4-98
Fig. 3. Reversible activation of an Rb kinase during meiotic maturation. A: Prophase oocytes (lane 1), metaphase II oocytes (lane 2) and ac-
tivated oocytes (lane 3) were homogenized and centrifuged at 15 000Ug. The 15 000Ug supernatants were incubated in the presence of
[Q-32P]ATP and GST-Rb bound on glutathione-Sepharose beads. After extensive washing, beads were resuspended in Laemmli sample bu¡er,
loaded on SDS-PAGE and autoradiographed. B: Prophase oocytes were microinjected with 0.1 mg/ml bacterially expressed GST-cyclin D2
(+D2) or with control bu¡er (3D2) and were incubated 2 h later in the presence of 1036 M progesterone. Prophase (Pro) and metaphase II
(MII) oocytes were then collected and the Rb kinase activity was assayed. C: A 15 000Ug supernatant from prophase (Pro) and metaphase II
(MII) oocytes was preincubated in the presence of control bu¡er (3), or 30 Wg/ml GST-cdk4 (cdk4) or 30 Wg/ml GST-cdk4 and 30 Wg/ml GST-
cyclin D2 (cdk4/cycD2) or 30 Wg/ml cyclin D2 (cycD2) or 25 Wg/ml GST-p16INK4 (p16) for 20 min at 23‡C. The extracts were then assayed for
Rb kinase activity. The position of GST-Rb is indicated on the right. Positions of molecular weight markers are indicated on the left (kDa).
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tracts, and very poorly phosphorylated by activated oocyte
extracts (Fig. 3A). In contrast, a strong phosphorylation oc-
curs with the metaphase oocyte extract (Fig. 3A), suggesting
that a Rb kinase is speci¢cally activated during meiotic matu-
ration and inactivated when oocytes reenter interphase after
activation. GST is not phosphorylated by the various extracts
(data not shown). By analyzing GST-Rb phosphorylation at
various times after progesterone addition, we have shown that
the Rb kinase is activated as soon as GVBD, and then re-
mains stable until metaphase II arrest, con¢rming the pre-
vious analysis of the altered migration of microinjected
GST-Rb (Fig. 2B).
3.4. Oocyte cdk2 and cdk4/6 kinases do not contribute to the
Rb kinase activity
Cyclin B-cdc2, cyclin A-cdc2 and cyclin D2-cdk4 complexes
are activated during meiotic maturation [22] and are therefore
potential candidates as Rb kinases. However, the cyclin E-
cdk2 complex is activated at the time of metaphase II, much
later than the Rb kinase activity.
In an attempt to identify the kinases responsible for Rb
phosphorylation at GVBD, we studied the ability of the var-
ious candidates, cdc2-cyclin B, cdc2-cyclin A and cdk2-cyclin
A, to phosphorylate Rb in vitro. Active cdc2-cyclin B was
isolated by immunoprecipitation with an anti-cyclin B anti-
body from metaphase oocytes. Xenopus cdc2, Xenopus cdk2
and human cyclin A were recombinant proteins, associated
and phosphorylated in vitro on threonine-161 and threo-
nine-160 of cdc2 and cdk2 respectively, as described previ-
ously [17,20]. As shown in Table 1, these three complexes
exhibit a lower speci¢c activity for Rb than for histone H1
in vitro.
Prophase oocytes were microinjected with Xenopus cyclin
D2 and then induced to mature by progesterone. The Rb
kinase activity was then assayed in prophase or metaphase
extracts from control or cyclin D2-injected oocytes. Cyclin
D2 microinjection did not increase the Rb kinase activity of
the oocyte (Fig. 3B). A similar experiment was performed in
vitro. We used a 15 000Ug extract from prophase and meta-
phase oocytes. The Rb kinase activity of these extracts is not
a¡ected by adding p16INK4, a speci¢c inhibitor of the cyclin D-
cdk4/6 family (Fig. 3C), suggesting that cyclin D-cdk4/6, if
present in the extracts, is not involved in Rb kinase activity.
Moreover, addition of either Xenopus cyclin D2, Xenopus
cdk4 or both proteins was unable to increase the Rb kinase
activity of a metaphase extract or to generate Rb kinase ac-
tivity in a prophase extract (Fig. 3C).
3.5. MAP kinase and cdc2-cyclin B complex could serve as
oocyte Rb kinases
Rb kinase is activated at GVBD, is stable until metaphase
II and is inactivated during activation, as the cell reenters
interphase. This activity pattern corresponds to the activity
pattern of cdc2-cyclin B kinase, of c-mos kinase and of
MAP kinase [1,23,24]. To determine whether these kinases
are involved in the phosphorylation of ectopic Rb, we took
advantage of a simpli¢ed in vitro system, consisting of a
100 000Ug supernatant from prophase oocytes. This extract
does not contain cdk2, c-mos kinase, cyclin E or cyclin A,
which are synthesized during meiotic maturation in response
to progesterone [22,24]. It contains inactive MAP kinase, as
judged by its electrophoretic mobility that is strictly correlated
with its phosphorylation state and its activity (Fig. 4A), in-
active cdc2-cyclin B as judged by histone H1 kinase assay of
p13-isolated cdc2 (Fig. 4B) and no Rb kinase activity (Fig.
4C). When the 100 000Ug supernatant from prophase oocytes
is supplemented with 500 nM okadaic acid, a speci¢c inhibitor
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Fig. 4. MAP kinase activity and cdc2 kinase contribute to the Rb
kinase activity. A 100 000Ug supernatant from prophase oocytes
was incubated for 3 h at 23‡C in the presence of either control bu¡-
er (lane 1) or 1 Wg/ml cdc25A (lane 2) or 500 nM okadaic acid
(lane 3) or 500 nM okadaic acid and 10 Wg/ml p21CIP1 (lane 4).
Samples were then collected for immunoblotting with an anti-MAP
kinase antibody (A), for p13 binding of cdc2 and histone H1 kinase
assay (B) and for Rb kinase assay on GST-Rb bound to gluta-
thione-Sepharose beads (C). Arrows on the right point to the posi-
tion of the two forms (active/inactive, respectively retarded/acceler-
ated migration) of MAP kinase (A), of radioactive phosphorylated
histone H1 (B) and of radioactive phosphorylated Rb (C).
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of phosphatase 2A known to activate cdc2-cyclin B and MAP
kinase after microinjection into prophase oocytes [25], both
cyclin B-cdc2 complex and MAP kinase are activated in the
extract (Fig. 4A,B). Under these conditions, a strong Rb kin-
ase activity is generated (Fig. 4C).
We then manipulated the prophase extract to activate cdc2-
cyclin B kinase without activating MAP kinase. Cdc25 is the
speci¢c phosphatase that directly dephosphorylates and acti-
vates the cdc2 kinase [26]. Addition in the prophase extract of
a recombinant form of the cdc25 phosphatase leads to the
speci¢c dephosphorylation of cdc2 and activation of the
cdc2-cyclin B complex (Fig. 4B). Under these conditions,
MAP kinase is not activated (Fig. 4A). A Rb kinase is acti-
vated (Fig. 4C), indicating that the main cdk-cyclin complex
of the oocyte, cdc2-cyclin B, contributes to the Rb kinase.
However, the activation level of the Rb kinase activity is low-
er than after activation in the extract of both MAP kinase and
cdc2-cyclin B kinase (Fig. 4C, lanes 2 and 3).
The reciprocal experiment was then conducted. MAP kin-
ase can be activated in the extract in the absence of cyclin B-
cdc2 kinase activity by adding 500 nM okadaic acid in the
presence of p21CIP1 that blocks cdc2 activation (Fig. 4A,B).
Under these conditions, the Rb kinase is activated, but again,
its level is decreased as compared to after okadaic acid addi-
tion alone (Fig. 4C). There is therefore an equal contribution
of MAP kinase and cdc2-cyclin B to the Rb kinase activity
under these conditions. The possibility that MAP kinase can
phosphorylate Rb was con¢rmed by an in vitro approach. A
constitutively active form of MAP kinase, a thiophosphoryl-
ated bacterially expressed histidine-tagged Xenopus MAP kin-
ase, was puri¢ed as described previously [18] and its activity
towards three di¡erent substrates, histone H1, MBP and
GST-Rb, was assayed (Table 1). Rb is a good in vitro sub-
strate of Xenopus MAP kinase (Table 1). GST is not phos-
phorylated by Xenopus MAP kinase in vitro (data not shown).
4. Discussion
4.1. A Rb kinase is activated during meiotic maturation
The Xenopus Rb protein is present at a low level and ex-
hibits only 56% overall identity with the amino acid sequence
of human Rb [11]. These observations explain why the various
monoclonal antibodies directed against human Rb that we
used recognize Xenopus Rb very poorly. To study the Rb
kinase activity, we took advantage of the possibility of micro-
injection in oocytes and we overexpressed in vivo a fusion
protein consisting of the large pocket of human Rb and
GST (GST-Rb). During meiotic maturation, GST-Rb is
clearly modi¢ed at GVBD: its migration in SDS-PAGE is
retarded and its a⁄nity towards a monoclonal anti-human
Rb antibody is decreased. These two modi¢cations are abol-
ished by in vitro phosphatase treatment, demonstrating that
they correspond to a phosphorylation event. By the same
approach, we demonstrated that GST-Rb is also phosphoryl-
ated in prophase non-stimulated oocytes, but to a much lesser
extent than at GVBD. We therefore concluded that Rb is
hypophosphorylated in prophase, a situation recalling the
G0 or early G1 status of Rb, and becomes hyperphosphoryl-
ated during meiotic maturation, as it happens starting the late
G1 until M phase of the somatic cell cycle [13]. When meta-
phase oocytes are activated and reenter interphase, Rb is de-
phosphorylated, as during the M/G1 transition of the cell
cycle. Interestingly, the levels of Rb kinase activity occurring
during meiotic maturation and activation mimic the phos-
phorylation events of Rb during a complete somatic cell cycle.
Xenopus oocytes therefore represent a good tool to get new
insights into the identity of Rb kinases.
4.2. The Rb kinase activated at GVBD does not correspond to
cdk2 and cdk4/6 kinases
In this report, we have shown that a Rb kinase activity is
activated during meiotic maturation, in good correlation with
the in vivo phosphorylation of the ectopic protein. Accumu-
lating evidence indicates that phosphorylation of Rb during
the somatic cell cycle is controlled by cyclin-cdk complexes. In
an oversimpli¢ed scheme, Rb phosphorylation would be ini-
tiated by cyclin D-cdk4/6 in mid/late G1 and maintained
through late G1, S and M successively by cyclin E-cdk2 and
cyclin A-cdk2/cdc2. Since all these complexes are activated
during meiotic maturation [22], they represent potential can-
didates as Rb kinases. However, inhibition of the cdk4/6 com-
plexes by p16INK4 inhibitor or overexpression of the cyclin D2-
cdk4 complex in vivo or in the extracts did not lead to any
variation of Rb kinase activity. Timing of synthesis and acti-
vation of cyclin E-cdk2 does not coincide with the appearance
of the Rb kinase activity [8,9] and cdk7 kinase activity does
not vary during oocyte maturation and early development
[27], excluding the participation of these cdks to the oocyte
Rb kinase activity.
4.3. MAP kinase and cdc2-cyclin B could contribute to the Rb
kinase activity
In parallel with the cdk pathway, progesterone induces the
synthesis of the c-mos proto-oncoprotein, which acts as a
MAP kinase kinase kinase and leads to the activation of
MAP kinase [2]. However, the c-raf kinase, another member
of the MAP kinase kinase kinase family, is also activated in
response to progesterone [3,4].
The kinase responsible for Rb phosphorylation in the oo-
cyte has to be activated at GVBD and inactivated after fer-
tilization. The cdc2-cyclin B complex and the kinases involved
in the MAP kinase cascade, such as c-mos, c-raf and MAP
kinase, exhibit this type of activity pattern [1]. All of them
could potentially serve as Rb kinases. C-mos, cyclin A, cyclin
E and cdk2 proteins are absent in prophase oocytes and are
synthesized in maturing oocytes in response to progesterone
[24]. In contrast, we have shown that the Rb kinase is present
in an inactive form in a high speed prophase extract and can
be activated in the extract upon addition of okadaic acid or
cdc25 phosphatase and independently of protein synthesis,
excluding the possibility that c-mos and cyclin A- or cyclin
E-dependent kinases could serve as Rb kinase in the oocyte.
Similarly, the Rb kinase activity remains stable in metaphase
extracts speci¢cally depleted of c-raf kinase (data not shown),
eliminating c-raf as Rb kinase.
In contrast, MAP kinase and the cdc2-cyclin B complex
appear to be good candidates as Rb kinase in the oocyte.
During progesterone-induced maturation, during fertilization
and in prophase extracts supplemented with either cdc25 or
okadaic acid, the activation of a Rb kinase correlates with the
presence of active MAP kinase and cdc2 kinase. By activating
both MAP kinase and cyclin B-cdc2 kinase in the prophase
extracts, the Rb kinase activity was strongly activated. By
selectively activating either MAP kinase or cdc2 kinase in
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the extracts, we were able to generate an intermediate level of
Rb kinase activity. These results strongly suggest that both
kinases contribute to the phosphorylation of Rb in the ex-
tract. MAP kinase belongs to the family of proline-directed
protein kinases, which also includes cdc2 and all cdks, and its
substrate speci¢city therefore overlaps with cdks [28]. This
could explain that a given protein can be phosphorylated
either by MAP kinase or by cdks following the physiological
status of the cell. Our results emphasize the parallel between
the signal transduction pathways involved in the somatic cell
responses and the hormonal triggering of maturation. They
support the hypothesis that the cyclin B-cdc2 complex could
serve as a Rb kinase during M phase. They open the possi-
bility that MAP kinase contributes to Rb phosphorylation at
the G0/G1 transition of the somatic cell cycle, a period when
transduction cascades implicating MAP kinase are induced by
growth factors and ultimately tie to elements of the cell cycle
such as Rb.
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